Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-01 Sale |
2025-07-03 4:30 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
80,000 | $42.63 | $3,410,450 | 1,173,090 (Indirect Direct) |
View |
| 2025-06-27 Sale |
2025-07-01 7:48 pm |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
3,500,000 | $44 | $154,000,000 | 18,555,375 (Indirect) |
View |
| 2025-06-26 Sale |
2025-06-30 5:51 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
4,707 | $44.05 | $207,327 | 7,863 (Indirect Direct) |
View |
| 2021-12-29 Purchase(A) |
2025-06-30 5:49 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
1,752 | $14.24 | $24,948 | 5,981 (Indirect Direct) |
View |
| 2021-12-28 Purchase(A) |
2025-06-30 5:46 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
2,338 | $12.84 | $30,028 | 4,229 (Indirect Direct) |
View |
| 2025-06-24 Sale |
2025-06-26 5:08 pm |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
100,000 | $44.23 | $4,422,800 | 963,254 (Indirect Direct) |
View |
| 2025-06-10 Sale |
2025-06-11 5:00 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
4,292 | $40 | $171,680 | 39,531 (Indirect Direct) |
View |
| 2025-05-19 Sale |
2025-05-20 6:06 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
101,156 | $33.38 | $3,376,741 | 6,635,244 (Indirect Direct) |
View |
| 2025-05-12 Sale |
2025-05-14 5:24 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
6,000,000 | $34.2 | $205,200,000 | 13,260,971 (Indirect) |
View |
| 2025-05-02 Sale |
2025-05-06 4:45 pm |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
1,026 | $38.51 | $39,509 | 147,639 (Direct) |
View |
| 2025-05-02 Sale |
2025-05-06 4:42 pm |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
100,000 | $38.5 | $3,849,900 | 153,682 (Indirect Direct) |
View |
| 2025-04-22 Sale |
2025-04-24 4:28 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
75,000 | $34.11 | $2,558,025 | 6,080,851 (Indirect Direct) |
View |
| 2025-04-14 Sale |
2025-04-16 5:39 pm |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $35 | $350,000 | 76,921 (Direct) |
View |
| 2025-04-01 Sale |
2025-04-03 5:11 pm |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $34.05 | $1,021,500 | 86,921 (Direct) |
View |
| 2025-03-25 Sale |
2025-03-27 4:54 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
75,000 | $36.87 | $2,764,943 | 6,155,851 (Indirect Direct) |
View |
| 2025-03-06 Sale |
2025-03-10 4:43 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $32.58 | $419,500 | 43,823 (Indirect Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 6:09 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
6,000,000 | $32.96 | $197,760,000 | 19,260,971 (Indirect) |
View |
| 2025-02-25 Sale |
2025-02-27 5:36 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $33.19 | $282,115 | 542,634 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-27 5:12 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
75,000 | $33.57 | $2,517,971 | 6,230,851 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-27 Gift |
2025-06-30 5:54 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
20,000 | $0 | 1,216,674 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:13 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
15,014 | $0 | 168,696 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:12 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
15,014 | $0 | 27,014 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:10 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director |
15,014 | $0 | 22,166 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:07 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
15,014 | $0 | 988,487 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:07 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director |
15,014 | $0 | 15,014 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:06 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
15,014 | $0 | 25,416 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 7:06 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
15,014 | $0 | 174,418 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:57 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
15,014 | $0 | 103,505 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:56 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
15,014 | $0 | 1,245,099 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:56 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
15,014 | $0 | 34,314 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:55 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
15,014 | $0 | 35,014 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:55 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
15,014 | $0 | 20,211 (Direct) |
View |
| 2025-06-20 Option Award |
2025-06-24 6:54 pm |
N/A 2035-06-19 |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
15,014 | $0 | 24,014 (Direct) |
View |
| 2025-06-10 Exercise |
2025-06-11 5:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
4,292 | $16.75 | 39,531 (Direct) |
View |
| 2025-06-10 Exercise |
2025-06-11 5:00 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
4,292 | $0 | 39,531 (Direct) |
View |
| 2025-05-16 Tax Withholding |
2025-05-20 6:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
32,854 | $33.84 | 6,635,244 (Direct) |
View |
| 2025-05-16 Exercise |
2025-05-20 6:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
129,392 | $0 | 6,635,244 (Direct) |
View |
| 2025-05-16 Tax Withholding |
2025-05-20 5:07 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO |
21,317 | $33.84 | 501,988 (Direct) |
View |
| 2025-05-16 Tax Withholding |
2025-05-20 5:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
4,780 | $33.84 | 142,859 (Direct) |
View |
| 2025-05-07 Gift |
2025-05-09 6:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
36,000 | $0 | 1,056,665 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:39 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $8.45 | 76,921 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:39 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $0 | 76,921 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:11 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $8.45 | 86,921 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:11 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $0 | 86,921 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:32 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO |
109,100 | $0 | 523,305 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:09 pm |
N/A 2035-03-18 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
256,068 | $0 | 256,068 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
23,660 | $0 | 148,665 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 4:43 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $16.75 | 43,823 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 4:43 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $0 | 43,823 (Direct) |
View |
Ownership |
2025-02-27 8:22 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
0 | $0 | 125,005 (Direct) |
View |
| 2025-02-25 Exercise |
2025-02-27 5:36 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $17 | 542,634 (Direct) |
View |
| 2025-02-25 Exercise |
2025-02-27 5:36 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $0 | 542,634 (Direct) |
View |